Free Trial

Alignment Healthcare (ALHC) Expected to Announce Quarterly Earnings on Wednesday

Alignment Healthcare logo with Medical background

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) is anticipated to issue its Q2 2025 quarterly earnings data after the market closes on Wednesday, July 30th. Analysts expect the company to announce earnings of ($0.07) per share and revenue of $960.25 million for the quarter. Alignment Healthcare has set its FY 2025 guidance at EPS and its Q2 2025 guidance at EPS.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported ($0.05) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.12) by $0.07. The business had revenue of $926.93 million during the quarter, compared to analysts' expectations of $889.83 million. Alignment Healthcare had a negative return on equity of 80.49% and a negative net margin of 3.02%. The company's revenue for the quarter was up 47.5% on a year-over-year basis. During the same quarter in the previous year, the business earned ($0.25) EPS. On average, analysts expect Alignment Healthcare to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.

Alignment Healthcare Stock Up 1.0%

Alignment Healthcare stock traded up $0.12 during midday trading on Friday, hitting $11.76. 3,724,000 shares of the company were exchanged, compared to its average volume of 2,984,283. The company's fifty day moving average price is $14.14 and its 200-day moving average price is $15.32. The company has a market cap of $2.33 billion, a PE ratio of -24.50 and a beta of 1.16. The company has a debt-to-equity ratio of 2.95, a current ratio of 1.69 and a quick ratio of 1.69. Alignment Healthcare has a fifty-two week low of $7.92 and a fifty-two week high of $21.06.

Insider Activity at Alignment Healthcare

In related news, President Dawn Christine Maroney sold 30,000 shares of the stock in a transaction dated Monday, July 14th. The stock was sold at an average price of $13.44, for a total value of $403,200.00. Following the completion of the sale, the president directly owned 2,042,899 shares of the company's stock, valued at approximately $27,456,562.56. This represents a 1.45% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CEO John E. Kao sold 180,000 shares of the company's stock in a transaction dated Thursday, July 10th. The stock was sold at an average price of $13.41, for a total value of $2,413,800.00. Following the completion of the transaction, the chief executive officer directly owned 1,553,100 shares in the company, valued at approximately $20,827,071. The trade was a 10.39% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders sold 17,685,262 shares of company stock valued at $269,685,496. Corporate insiders own 7.00% of the company's stock.

Institutional Trading of Alignment Healthcare

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in ALHC. Goldman Sachs Group Inc. lifted its position in shares of Alignment Healthcare by 79.1% during the 1st quarter. Goldman Sachs Group Inc. now owns 972,715 shares of the company's stock worth $18,112,000 after buying an additional 429,703 shares during the period. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in shares of Alignment Healthcare by 16.9% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 307,655 shares of the company's stock worth $5,729,000 after acquiring an additional 44,452 shares during the last quarter. Woodline Partners LP bought a new stake in shares of Alignment Healthcare during the first quarter worth $2,142,000. Royal Bank of Canada grew its stake in shares of Alignment Healthcare by 92.6% during the first quarter. Royal Bank of Canada now owns 92,379 shares of the company's stock worth $1,720,000 after purchasing an additional 44,413 shares during the period. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its stake in Alignment Healthcare by 4.6% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 59,557 shares of the company's stock valued at $1,109,000 after acquiring an additional 2,594 shares during the period. Institutional investors and hedge funds own 86.19% of the company's stock.

Analysts Set New Price Targets

Several equities research analysts recently issued reports on ALHC shares. Stifel Nicolaus upped their price target on Alignment Healthcare from $18.00 to $23.00 and gave the company a "buy" rating in a research report on Tuesday, April 8th. Robert W. Baird increased their price target on Alignment Healthcare from $17.00 to $22.00 and gave the stock an "outperform" rating in a research note on Tuesday, April 15th. Stephens raised Alignment Healthcare to a "strong-buy" rating in a research note on Monday, June 2nd. Finally, UBS Group upped their price objective on Alignment Healthcare from $16.00 to $17.00 and gave the company a "neutral" rating in a report on Friday, May 2nd. One equities research analyst has rated the stock with a sell rating, three have given a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $17.17.

Read Our Latest Stock Analysis on Alignment Healthcare

About Alignment Healthcare

(Get Free Report)

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

Read More

Earnings History for Alignment Healthcare (NASDAQ:ALHC)

Should You Invest $1,000 in Alignment Healthcare Right Now?

Before you consider Alignment Healthcare, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alignment Healthcare wasn't on the list.

While Alignment Healthcare currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 “Boring” Mega Cap Stocks to Turn Into Pure Profit
Joby vs. Archer: The $10 Billion eVTOL Battle
3 Small-Cap Biotech Stocks With Catalysts Too Big to Ignore

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines